Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies by Hervé Lang, Claire Béraud, Luc Cabel, Luc Cabel, Jacqueline Fontugne, Jacqueline Fontugne, Jacqueline Fontugne, Myriam Lassalle, Clémentine Krucker, Clémentine Krucker, Clémentine Krucker, Florent Dufour, Florent Dufour, Florent Dufour, Clarice S. Groeneveld, Clarice S. Groeneveld, Clarice S. Groeneveld, Victoria Dixon, Victoria Dixon, Victoria Dixon, Xiangyu Meng, Xiangyu Meng, Xiangyu Meng, Aurélie Kamoun, Elodie Chapeaublanc, Elodie Chapeaublanc, Aurélien De Reynies, Xavier Gamé, Pascal Rischmann, Ivan Bieche, Julien Masliah-Planchon, Romane Beaurepere, Yves Allory, Yves Allory, Yves Allory, Véronique Lindner, Yolande Misseri, François Radvanyi, François Radvanyi, Philippe Lluel, Isabelle Bernard-Pierrot, Isabelle Bernard-Pierrot, Thierry Massfelder

Get full text

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer by A. Gordon Robertson, Khyati Meghani, Lauren Folgosa Cooley, Kimberly A. McLaughlin, Leigh Ann Fall, Yanni Yu, Mauro A. A. Castro, Clarice S. Groeneveld, Aurélien de Reyniès, Vadim I. Nazarov, Vasily O. Tsvetkov, Bonnie Choy, Daniele Raggi, Laura Marandino, Francesco Montorsi, Thomas Powles, Andrea Necchi, Joshua J. Meeks

Get full text